Smoltek Nanotech Holding AB (publ) (“Smoltek”) today publishes its interim report for the second quarter of 2026 – a period characterized by continued focus on commercialization and industrial scale-up in semiconductors and hydrogen.

Smoltek’s President & CEO, Magnus Andersson, comments on the interim report: 
The most important event of the period was the heavily oversubscribed rights issue, which together with the over-allotment issue provided the company with approximately SEK 82 million before issue costs and offset of loans.

Smoltek Semi – ultra-thin capacitors for AI chips and data centers 
Smoltek Semi continues to develop the CNF-MIM technology towards commercial products. Customer contacts were intensified during the quarter, including through visits to Taiwan and participation in Yageo Group’s AI Summit – important activities in one of the world’s leading ecosystems for electronics and semiconductors.

The technology has potential in several growing segments, especially RF and optoelectronics, with significant long-term potential also in advanced power supply for AI infrastructure and data centers. The focus is now on customer validation and building the conditions for industrialization.

Smoltek Hydrogen – iridium-saving electrodes for PEM electrolysis 
Smoltek Hydrogen develops electrode technology for PEM electrolyzers and fuel cells with the goal of significantly reducing the need for critical precious metals such as iridium and platinum. The technology thus addresses a key bottleneck for the global scale-up of green hydrogen.

The collaboration with Heraeus Precious Metals is an important part of the path towards commercialization of next-generation porous transport electrodes with ultra-low iridium content. After the end of the quarter, plans for a joint 3,000-hour durability test were also announced – an important step in the technical and commercial validation.

See also  Norse Atlantic ASA: Invitation to presentation of the Q2 2026 results

During the quarter, Gabriel Altby took office as new CFO, and in June, Magnus Andersson also took over the role of President of Smoltek Hydrogen. After the end of the quarter, Smoltek also joined Maxbatt, a national industry consortium that creates opportunities to evaluate the company’s core technology within next-generation battery technology and electrification.

The full interim report is available on the company’s website.

Financial summary for the second quarter of 2026:

  • Net sales: SEK 0 thousand (44)
  • Consolidated result: SEK -10,919 thousand (-10,009), which primarily reflects high activity in R&D and strategic investments, which strengthens long-term revenue opportunities
  • Earnings per share for the second quarter were -0.06 SEK (-0.12) before dilution
  • Equity ratio: 70.9% (72.4)
  • Cash and cash equivalents: SEK 1,856 thousand (4,717)
  • Equity: SEK 126,341 thousand (85,870)
  • Cash flow from operating activities: SEK 4,452 thousand (-10,009)



For further information:
Magnus Andersson,
CEO of Smoltek Nanotech Holding AB
Email: magnus.andersson@smoltek.com  
Phone: +46
317 01 03 05
Website: www.smoltek.com/investors   

Smoltek Nanotech Holding is a public technology company that provides a technology that enables the production of conductive nanostructures on various materials. The company’s technology multiplies the actual surface area for electrical and chemical processes and can be used in several industrial sectors. Customers are found in semiconductors and the global process industry. The products that the company develops are used as infrastructure components for stable power supply microchips and as electrodes and surface structures in equipment for the production and use of fossil-free hydrogen. The company protects its unique carbon nanotechnology through an extensive patent portfolio. Smoltek’s share is listed on the Spotlight Stock Market under the ticker SMOL. Smoltek is a development company and forward-looking statements regarding time to market, production volume and price levels should be interpreted as forecasts and not commitments.

See also  Implantica receives FDA approval for RefluxStop® – Opening the U.S. market


Source link

Author

Shin John
Shin JohnYtv Market News
Share-market news writer and analyst with deep experience covering equities, commodities, forex, and cryptocurrencies for readers in the USA, UK, Canada, and Australia. Ytv Market News delivers timely market updates, practical trading insights, and clear explanations of macro and company-level catalysts that move prices. Combines on-the-ground financial reporting with technical analysis, using concise charts and actionable ideas to help investors and traders make smarter decisions.